Denali Therapeutics (DNLI) Property, Plant & Equipment (Net) (2017 - 2026)
Denali Therapeutics (DNLI) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 34.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.64 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 554.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | 49.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.93 Mn |
| Jun 30, 2026 | 49.93 Mn |
| Mar 31, 2026 | 51.73 Mn |
| Mar 31, 2026 | 51.73 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Sep 30, 2025 | 53.73 Mn |
| Sep 30, 2025 | 53.73 Mn |
| Jun 30, 2025 | 58.72 Mn |
| Jun 30, 2025 | 58.72 Mn |
| Mar 31, 2025 | 57.77 Mn |
| Mar 31, 2025 | 57.77 Mn |
| Dec 31, 2024 | 55.24 Mn |
| Dec 31, 2024 | 55.24 Mn |
| Sep 30, 2024 | 50.82 Mn |
| Sep 30, 2024 | 50.82 Mn |
| Jun 30, 2024 | 48.08 Mn |
| Jun 30, 2024 | 48.08 Mn |
| Mar 31, 2024 | 46.86 Mn |
| Mar 31, 2024 | 46.86 Mn |